This website uses cookies

Read our Privacy policy and Terms of use for more information.

AI Regulations

LATEST

#0112: FDA's New AI Guidance and the Rise of Continuous AI Credibility in GxP Operations

ContinuousOS

+1

#0112: FDA's New AI Guidance and the Rise of Continuous AI Credibility in GxP Operations

Nagesh Nama, +2

•

Jun 12, 2026

#0103: AI Governance in Life Sciences : From Principles to Regulatory-Ready Execution (Part 3)

AI Regulations

#0103: AI Governance in Life Sciences : From Principles to Regulatory-Ready Execution (Part 3)

Nagesh Nama, +1

•

Apr 8, 2026

#0101: AI Governance in GxP: From Principles to Practice (Part 2)

AI Regulations

#0101: AI Governance in GxP: From Principles to Practice (Part 2)

Nagesh Nama, +1

•

Mar 26, 2026

#0100: AI & GxP Regulatory Current Moments (Part 1) - 10 Guiding Principles from FDA/EMA

AI Agentic Continuous Validation

+3

#0100: AI & GxP Regulatory Current Moments (Part 1) - 10 Guiding Principles from FDA/EMA

Nagesh Nama, +1

•

Mar 20, 2026

#099: Governing AI in Regulated Pharma R&D: Lessons from Merck’s Research Quality Leadership

LinkedIn Live

+1

#099: Governing AI in Regulated Pharma R&D: Lessons from Merck’s Research Quality Leadership

Nagesh Nama, +1

•

Mar 11, 2026

#098: Regulatory Alert: UK Makes AI/ML Usage Transparent in Clinical Trials

AI Regulations

+1

#098: Regulatory Alert: UK Makes AI/ML Usage Transparent in Clinical Trials

Nagesh Nama, +1

•

Mar 5, 2026